These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 12068841

  • 1. Sublingual apomorphine: new preparation. In erectile disorders: a narrow therapeutic margin.
    Prescrire Int; 2002 Jun; 11(59):76-9. PubMed ID: 12068841
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Comparative cross-over study of sildenafil and apomorphine for treating erectile dysfunction.
    Afif-Abdo J, Teloken C, Damião R, Koff W, Wroclawski E, Yamasaki R, Torres LO, Sabaneeff J, Faria G, Pompeo AC, Cortado P, Glina S.
    BJU Int; 2008 Sep; 102(7):829-34. PubMed ID: 18537952
    [Abstract] [Full Text] [Related]

  • 4. Commentary on apomorphine versus sildenafil for erectile dysfunction.
    Carson CC.
    J Urol; 2008 May; 179(5 Suppl):S95-6. PubMed ID: 18405768
    [No Abstract] [Full Text] [Related]

  • 5. Efficacy of apomorphine and sildenafil in men with nonarteriogenic erectile dysfunction. A comparative crossover study.
    Perimenis P, Markou S, Gyftopoulos K, Giannitsas K, Athanasopoulos A, Liatsikos E, Barbalias G.
    Andrologia; 2004 Jun; 36(3):106-10. PubMed ID: 15206909
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Safety and tolerability of apomorphine SL (Uprima).
    Bukofzer S, Livesey N.
    Int J Impot Res; 2001 Aug; 13 Suppl 3():S40-4. PubMed ID: 11477491
    [Abstract] [Full Text] [Related]

  • 8. Sildenafil citrate for erectile dysfunction in men with diabetes and cardiovascular risk factors: a retrospective analysis of pooled data from placebo-controlled trials.
    Blonde L.
    Curr Med Res Opin; 2006 Nov; 22(11):2111-20. PubMed ID: 17076971
    [Abstract] [Full Text] [Related]

  • 9. A comparative, crossover study of the efficacy and safety of sildenafil and apomorphine in men with evidence of arteriogenic erectile dysfunction.
    Perimenis P, Gyftopoulos K, Giannitsas K, Markou SA, Tsota I, Chrysanthopoulou A, Athanasopoulos A, Barbalias G.
    Int J Impot Res; 2004 Feb; 16(1):2-7. PubMed ID: 14963464
    [Abstract] [Full Text] [Related]

  • 10. Update on oral treatments for male erectile dysfunction.
    Kalsi JS, Kell PD.
    J Eur Acad Dermatol Venereol; 2004 May; 18(3):267-74. PubMed ID: 15096134
    [Abstract] [Full Text] [Related]

  • 11. [New treatment options for erectile dysfunction. Pharmacologic and nonpharmacologic options].
    Sperling H, Lümmen G, Schneider T, Rübben H.
    Herz; 2003 Jun; 28(4):314-24. PubMed ID: 12825147
    [Abstract] [Full Text] [Related]

  • 12. An open-label, randomized, flexible-dose, crossover study to assess the comparative efficacy and safety of sildenafil citrate and apomorphine hydrochloride in men with erectile dysfunction.
    Eardley I, Wright P, MacDonagh R, Hole J, Edwards A.
    BJU Int; 2004 Jun; 93(9):1271-5. PubMed ID: 15180621
    [Abstract] [Full Text] [Related]

  • 13. Comparative trial of treatment satisfaction, efficacy and tolerability of sildenafil versus apomorphine in erectile dysfunction--an open, randomized cross-over study with flexible dosing.
    Porst H, Behre HM, Jungwirth A, Burkart M.
    Eur J Med Res; 2007 Feb 26; 12(2):61-7. PubMed ID: 17369119
    [Abstract] [Full Text] [Related]

  • 14. Tolerability and safety of apomorphine SL (Ixense (TM) ).
    Montorsi F.
    Int J Impot Res; 2003 Apr 26; 15 Suppl 2():S7-9. PubMed ID: 12825097
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Tadalafil: new preparation. Slightly more convenient, but poorly assessed in organic disorders.
    Prescrire Int; 2003 Dec 26; 12(68):213-5. PubMed ID: 14986690
    [Abstract] [Full Text] [Related]

  • 18. Pharmacotherapy of erectile dysfunction: focus on cardiovascular safety.
    Reffelmann T, Kloner RA.
    Expert Opin Drug Saf; 2005 May 26; 4(3):531-40. PubMed ID: 15934858
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.